BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 18369380)

  • 1. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
    Tong AW; Nemunaitis J
    Cancer Gene Ther; 2008 Jun; 15(6):341-55. PubMed ID: 18369380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs: small but potent oncogenes or tumor suppressors.
    Lee YS; Dutta A
    Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
    Blenkiron C; Miska EA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target identification of microRNAs expressed highly in human embryonic stem cells.
    Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
    J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A miRNA signature of prion induced neurodegeneration.
    Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
    PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular therapy in the microRNA era.
    Wurdinger T; Costa FF
    Pharmacogenomics J; 2007 Oct; 7(5):297-304. PubMed ID: 17189960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of miR-106a predicts survival in human colon cancer patients.
    Díaz R; Silva J; García JM; Lorenzo Y; García V; Peña C; Rodríguez R; Muñoz C; García F; Bonilla F; Domínguez G
    Genes Chromosomes Cancer; 2008 Sep; 47(9):794-802. PubMed ID: 18521848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.
    Diederichs S; Haber DA
    Cancer Res; 2006 Jun; 66(12):6097-104. PubMed ID: 16778182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
    Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
    Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
    Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential role of microRNAs in human diseases and the exploration on design of small molecule agents].
    Zhang Y; Lu YJ; Yang BF
    Yao Xue Xue Bao; 2007 Nov; 42(11):1115-21. PubMed ID: 18300464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
    Wu W; Lin Z; Zhuang Z; Liang X
    Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts.
    Maes OC; Sarojini H; Wang E
    J Cell Physiol; 2009 Oct; 221(1):109-19. PubMed ID: 19475566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
    Ahmed FE
    Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-21 as a key regulator of oncogenic processes.
    Selcuklu SD; Donoghue MT; Spillane C
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):918-25. PubMed ID: 19614619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and cancer.
    Cowland JB; Hother C; Grønbaek K
    APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.